Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 28, 2013; 19(48): 9256-9270
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9256
Published online Dec 28, 2013. doi: 10.3748/wjg.v19.i48.9256
Intoxications | Pathogenetic mechanisms | Curcumin effects |
Iron (alcoholic liver disease; steatosis, viral hepatitis; anemia) | Fibrosis induced by oxidation | Anti-oxidant enzymatic activity |
Alcohol (chronic or acute intoxication) | Phospholipase A2 activation | Phospholipase A2 inhibition by NF-κB |
High-fat diet (lipid storage) | Focal degeneration, micronecrosis | Acil-CoA, cholesterol biliary acids; LDL peroxidation |
Xenobiotics induced acute damage | ROS, lipid peroxidation, inflammation | Scavenger activity on NF-κB; anti-oxidant enzymatic activity |
Xenobiotics induced chronic damage | Inflammation and hepatocellular necrosis | Hepatic fibrosis inhibition by NF-κB |
Poisons (carbon tetrachloride) | Inflammatory self-maintenance | Hepatic inflammation inhibition by NF-κB |
- Citation: Dulbecco P, Savarino V. Therapeutic potential of curcumin in digestive diseases. World J Gastroenterol 2013; 19(48): 9256-9270
- URL: https://www.wjgnet.com/1007-9327/full/v19/i48/9256.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i48.9256